Scarica l'app Stockscreener
25.13
0.36%
-0.09
Precedente Chiudi:
$25.22
Aprire:
$25.32
Volume 24 ore:
174.63K
Relative Volume:
0.93
Capitalizzazione di mercato:
$1.11B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+10.36%
1M Prestazione:
+31.57%
6M Prestazione:
+70.26%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$24.48
$25.88
Intervallo di 1 settimana:
$20.95
$25.88
Portata 52W:
$7.255
$25.88
Sionna Therapeutics Inc Stock (SION) Company Profile
Nome
Sionna Therapeutics Inc
Settore
Industria
Telefono
617-819-2020
Indirizzo
21 HICKORY DRIVE, SUITE 500, WALTHAM
Confronta SION con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
25.13 | 1.11B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-04 | Iniziato | Guggenheim | Buy |
| 2025-03-04 | Iniziato | Stifel | Buy |
| 2025-03-04 | Iniziato | TD Cowen | Buy |
Sionna Therapeutics Inc Borsa (SION) Ultime notizie
Real time scanner hits for Sionna Therapeutics Inc. explainedQuarterly Investment Review & AI Enhanced Execution Alerts - Newser
What the charts say about Sionna Therapeutics Inc. todayQuarterly Trade Report & Weekly Momentum Picks - Newser
How moving averages guide Sionna Therapeutics Inc. tradingQuarterly Portfolio Summary & AI Based Buy and Sell Signals - Newser
Will Sionna Therapeutics Inc. outperform the marketJuly 2025 PreEarnings & Risk Controlled Daily Trade Plans - Newser
Combining price and volume data for Sionna Therapeutics Inc.2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Real time pattern detection on Sionna Therapeutics Inc. stockPortfolio Update Report & Fast Momentum Stock Entry Tips - Newser
Sionna Therapeutics Inc. recovery potential after sell offJuly 2025 Patterns & Stock Market Timing Techniques - Newser
What institutional flow reveals about Sionna Therapeutics Inc.July 2025 Recap & Fast Gain Swing Alerts - Newser
Detecting support and resistance levels for Sionna Therapeutics Inc.Earnings Overview Summary & AI Driven Price Predictions - Newser
Using data filters to optimize entry into Sionna Therapeutics Inc.Weekly Trade Summary & AI Enhanced Trading Signals - Newser
Will Sionna Therapeutics Inc. price bounce be sustainable2025 Price Targets & Free Real-Time Volume Trigger Notifications - Newser
Custom strategy builders for tracking Sionna Therapeutics Inc.July 2025 Trade Ideas & Daily Market Momentum Tracking - Newser
Sionna Therapeutics Inc. stock outlook for YEAR2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
Can Sionna Therapeutics Inc. recover in the next quarterJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - Newser
Real time social sentiment graph for Sionna Therapeutics Inc.July 2025 Price Swings & Accurate Intraday Trading Signals - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Reactions & High Yield Stock Recommendations - Newser
Comparing Sionna Therapeutics Inc. in custom built stock radarsWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Why Sionna Therapeutics Inc. is moving todayQuarterly Investment Review & Weekly Hot Stock Watchlists - Newser
How to use a screener to detect Sionna Therapeutics Inc. breakoutsRate Hike & Technical Confirmation Trade Alerts - Newser
How to track smart money flows in Sionna Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - Newser
Quantitative breakdown of Sionna Therapeutics Inc. recent moveTrade Entry Report & Weekly Setup with ROI Potential - Newser
Sionna Therapeutics to Participate in Upcoming September Investor Conferences - The Manila Times
CF Drug Developer Sionna Therapeutics to Present at Major September Healthcare Conferences in NYC - Stock Titan
Sionna Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewswire Inc.
When is the best time to exit Sionna Therapeutics Inc.Gold Moves & Real-Time Price Movement Reports - Newser
Will earnings trigger a reversal in Sionna Therapeutics Inc.2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
What machine learning models say about Sionna Therapeutics Inc.Weekly Trend Summary & Entry Point Confirmation Signals - Newser
Sionna Therapeutics Inc. stock prediction for this weekIndex Update & Weekly Breakout Stock Alerts - Newser
Trend analysis for Sionna Therapeutics Inc. this weekBull Run & Consistent Return Strategy Ideas - Newser
Study testing combination of CFTR modulators begins dosing volunteers - Cystic Fibrosis News Today
Sentiment analysis tools applied to Sionna Therapeutics Inc.July 2025 Institutional & Verified Short-Term Plans - Newser
Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis - MarketScreener
Sionna Therapeutics begins phase 1 trial of CF dual combinations By Investing.com - Investing.com Canada
Sionna Therapeutics Announces First Subjects Dosed in Phase - GlobeNewswire
First-Ever NBD1 Stabilizer: Sionna's Groundbreaking CF Treatment Enters Clinical Testing for 100K Patients - Stock Titan
Sionna Therapeutics Inc. Volume Confirms Breakout — Analysts BullishJuly 2025 Movers & Safe Capital Growth Trade Ideas - Newser
What’s next for Sionna Therapeutics Inc. stock priceQuarterly Profit Summary & Precise Buy Zone Identification - Newser
Sionna Therapeutics Inc Azioni (SION) Dati Finanziari
Non sono disponibili dati finanziari per Sionna Therapeutics Inc (SION). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):